Page last updated: 2024-10-17

lactic acid and Blastomyces brasiliensis Infection

lactic acid has been researched along with Blastomyces brasiliensis Infection in 5 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"The D-AMB-coated PLGA-DMSA nanoparticle showed antifungal efficacy, fewer undesirable effects and a favourable extended dosing interval."1.35Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis. ( Amaral, AC; Bentes, R; Bocca, AL; Felipe, MS; Lacava, ZG; Morais, PC; Nunes, J; Peixoto, DL; Primo, FL; Ribeiro, AM; Simioni, AR; Tedesco, AC; Titze-de-Almeida, R, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jannuzzi, GP1
Souza, NA1
Françoso, KS1
Pereira, RH1
Santos, RP1
Kaihami, GH1
Almeida, JRF1
Batista, WL1
Amaral, AC5
Maranhão, AQ1
Almeida, SR1
Ferreira, KS1
Ribeiro, AM2
Souza, AC2
Vasconcelos, NM1
Jeronimo, MS2
Carneiro, FP1
Faccioli, LH1
Felipe, MS4
Silva, CL1
Bocca, AL4
Nascimento, AL1
de Vasconcelos, NM1
Siqueira, IM1
R-Santos, L1
Cintra, DO1
Fuscaldi, LL1
Pires Júnior, OR1
Titze-de-Almeida, R2
Borin, MF1
Báo, SN1
Martins, OP1
Cardoso, VN1
Fernandes, SO1
Mortari, MR1
Tedesco, AC3
Nunes, J1
Peixoto, DL1
Simioni, AR2
Primo, FL1
Lacava, ZG1
Bentes, R1
Morais, PC2
Marques, AF1
Muñoz, JE1
Travassos, LR1
Taborda, CP1

Other Studies

5 other studies available for lactic acid and Blastomyces brasiliensis Infection

ArticleYear
Therapeutic treatment with scFv-PLGA nanoparticles decreases pulmonary fungal load in a murine model of paracoccidioidomycosis.
    Microbes and infection, 2018, Volume: 20, Issue:1

    Topics: Animals; Antibodies, Fungal; Antigens, Fungal; Colony Count, Microbial; Cytokines; Dendritic Cells;

2018
Nanobiotechnological approaches to delivery of DNA vaccine against fungal infection.
    Journal of biomedical nanotechnology, 2013, Volume: 9, Issue:2

    Topics: Animals; Bacterial Proteins; Biotechnology; Cell Proliferation; Chaperonin 60; Cytokines; Fungal Vac

2013
Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
    European journal of medicinal chemistry, 2015, May-05, Volume: 95

    Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Carriers; Drug Combinations; Drug

2015
Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:3

    Topics: Amphotericin B; Animals; Body Weight; Bone Marrow; Colony Count, Microbial; Deoxycholic Acid; Drug C

2009
Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.
    British journal of pharmacology, 2010, Volume: 159, Issue:5

    Topics: Animals; Anti-Infective Agents; Delayed-Action Preparations; Disease Models, Animal; Dose-Response R

2010